|
Indicator: 1
[Output]
Measurements in/of Recommendations Made
Relationships: Department of Health and Human Services - Narrower_Than
Other Information:
National Cancer Institute Clinical Trials and Translational Research Advisory Committee
| Type |
Target |
Actual |
| StartDate |
2010-10-01 |
2010-10-01 |
| EndDate |
2011-09-30 |
2011-09-30 |
| Number |
n/a |
36 |
| Description |
Unspecified |
(27) The Committee approved the minutes of the 10th meeting of the NCI CTAC held on March 10, 2010. (28) A motion to accept
the Process to Accelerate Translational Science (PATS) Working Group report and recommendations with the modification that
a pathway prioritization effort must be included was approved (29) A motion to accept the Cost Effectiveness Analysis Working
Group report and recommendations on a pilot basis was approved. (30) The Committee approved the minutes of the 11th meeting
of the NCI CTAC held on September 15, 2010. (31) The Committee approved the minutes of the 12th meeting of the NCI CTAC held
on December 15, 2010. (32) The Committee approved a motion to set up a working group to analyze NCI’s clinical trials portfolio
and make in-depth recommendations on how to rebuild and manage the clinical trial system and portfolio process. (33) A motion
to accept the minutes of the 13th meeting of the NCI CTAC held on March 3, 2011, was approved. (34) A motion was made to accept
the final report of the Clinical Trials Working Group (CTWG) Evaluation Working Group was approved with the provision that
the role of the Patient Advocate Steering Committee (PASC) be corrected in the report. (35) A motion to establish an Ad hoc
Clinical Trials Strategic Planning Subcommittee was approved. (36) A motion to establish an Ad hoc Clinical Trials Informatics
Subcommittee was approved.
|
|
